ResearcherUniversity of California, San FranciscoActive in the last 2 years
Amir Ashraf‐Ganjouei
Matched on ORCID iD 0000-0003-2745-5032; OpenAlex author ID A5044110862. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 1 paper · 2025: 1 paper · 2026: 3 papers
Papers 5
- A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/sla.0000000000006506↗
- Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival. Co-author DOI 10.1245/s10434-026-19829-1↗
- ASO Author Reflection: Are Survival Gains with Neoadjuvant Therapy in Resectable PDAC Real? The Hidden Impact of Immortal Time Bias. Co-author DOI 10.1245/s10434-026-19963-w↗
- Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. First author DOI 10.3390/cancers17020170↗
- Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/curroncol31090370↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mohamed A. Adam · 5 shared papers, 2024–2026 · strength 1.45
- Paper ASO Author Reflection: Are Survival Gains with Neoadjuvant Therapy in Resectable PDAC Real? The Hidden Impact of Immort… DOI 10.1245/s10434-026-19963-w↗
- Paper Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impac… DOI 10.1245/s10434-026-19829-1↗
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Adnan A. Alseidi · 4 shared papers, 2024–2026 · strength 0.95
- Paper Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impac… DOI 10.1245/s10434-026-19829-1↗
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
- Eric K. Nakakura · 3 shared papers, 2024–2026 · strength 0.71
- Paper Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impac… DOI 10.1245/s10434-026-19829-1↗
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
- Jane Wang · 3 shared papers, 2024–2026 · strength 0.66
- Paper Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. DOI 10.3390/cancers17020170↗
- Paper A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients With Pancreatic Ductal Ade… DOI 10.1097/sla.0000000000006506↗
- Paper Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/curroncol31090370↗
- Sophia Hernandez · 2 shared papers, 2025–2026 · strength 0.53
- J. Ejie · 1 shared paper, 2025 · strength 0.24
- Timothy R. Donahue · 1 shared paper, 2026 · strength 0.24
- Neema Jamshidi · 1 shared paper, 2026 · strength 0.24
- Han Yin · 1 shared paper, 2024 · strength 0.18
- June S. Peng · 1 shared paper, 2024 · strength 0.18
- Ajay V. Maker · 1 shared paper, 2024 · strength 0.18
- Kimberly Saunders Kirkwood · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.